Physician profile
Michael Gordon
NPI 1851489355
$103,482.10
in general payments reported to CMS, 2019-2025
22 companies · $2,189 in 2025
The $2,189 reported for 2025 was more than what 89% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25K · 2020: $13K · 2021: $3,262 · 2022: $6,196 · 2023: $15K · 2024: $39K · 2025: $2,189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $42K · Travel and Lodging: $8,629 · Food and Beverage: $4,666 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $700.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $41,650.00 |
| Travel and Lodging | $8,629.32 |
| Food and Beverage | $4,666.22 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $700.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $63,313.42 | 2019-2025 | Wavelight Refractive Suite, Clareon, Wavelight Ex500 Excimer Laser |
| Alcon Research LLC | $36,593.50 | 2019-2024 | Wavelight Refractive Suite |
| Glaukos Corporation | $1,009.51 | 2021-2025 | Idosetr, Istent Infinite, Kxl System |
| Avedro INC. | $1,000.00 | 2019 | |
| Bausch & Lomb Americas INC. | $247.05 | 2022-2025 | Miebo, Vyzulta, Xiidra |
| Depuy Synthes Sales INC. | $227.13 | 2020-2021 | |
| Harrow Eye, LLC | $169.87 | 2024-2025 | Vevye |
| Sight Sciences, INC. | $148.20 | 2025 | Omni Surgical System, Sion Surgical Instrument |
| Biotissue Holdings INC. | $136.81 | 2019-2024 | |
| Sun Pharmaceutical Industries INC. | $112.99 | 2019-2025 | Cequa |
| Novartis Pharmaceuticals Corporation | $95.30 | 2019-2020 | |
| Tarsus Pharmaceuticals, INC. | $83.74 | 2024-2025 | Xdemvy |
| Shire North American Group INC | $64.65 | 2019 | |
| Dompe US, INC. | $63.22 | 2025 | Oxervate |
| Oyster Point Pharma, INC. | $42.62 | 2022-2023 | Tyrvaya |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $35.87 | 2022-2023 | |
| Rxsight INC | $28.68 | 2020-2023 | Rxsight Contact Lens, Rxsight Light Adjustable Lens (Rxlal), Rxsight Injector Cartridge |
| Allergan, INC. | $24.78 | 2019 | |
| Thea Pharma INC. | $23.14 | 2025 | Iyuzeh |
| Ocular Therapeutix, INC. | $22.97 | 2020 | |
| Mallinckrodt Hospital Products INC. | $19.43 | 2021 | |
| Aerie Pharmaceuticals, INC. | $19.22 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Gordon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.